Filing Details

Accession Number:
0001138639-18-000011
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-02-14 18:06:45
Reporting Period:
2018-02-12
Accepted Time:
2018-02-14 18:06:45
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1138639 Infinera Corp INFN Telephone & Telegraph Apparatus (3661) 770560433
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1399122 F David Welch C/O Infinera Corporation
140 Caspian Court
Sunnyvale CA 94089
Chief Strategy & Tech. Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2018-02-12 60,000 $9.07 684,351 No 4 S Indirect See Footnote
Common Stock Disposition 2018-02-14 20,000 $9.34 664,351 No 4 S Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See Footnote
No 4 S Indirect See Footnote
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 292,293 Indirect See Footnote
Common Stock 528,150 Indirect See Footnote
Common Stock 140,000 Indirect See Footnote
Common Stock 2,500 Indirect See Footnote
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Employee Stock Option (Right to Buy) $7.61 2018-02-28 2,817 2,817 Direct
Common Stock Employee Stock Option (Right to Buy) $7.61 2018-02-28 81,683 81,683 Direct
Common Stock Employee Stock Option (Right to Buy) $7.11 2019-02-10 100,000 100,000 Direct
Common Stock Employee Stock Option (Right to Buy) $7.45 2019-08-10 150,000 150,000 Direct
Common Stock Employee Stock Option (Right to Buy) $8.58 2021-02-10 20,250 20,250 Direct
Common Stock Employee Stock Option (Right to Buy) $8.58 2021-02-10 60,750 60,750 Direct
Common Stock Employee Stock Option (Right to Buy) $8.58 2021-02-10 39,465 39,465 Direct
Common Stock Employee Stock Option (Right to Buy) $8.58 2021-02-10 41,535 41,535 Direct
Common Stock Restricted Stock Units $0.00 9,590 9,590 Direct
Common Stock Restricted Stock Units $0.00 14,385 14,385 Direct
Common Stock Restricted Stock Units $0.00 65,137 65,137 Direct
Common Stock Restricted Stock Units $0.00 114,831 114,831 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2018-02-28 2,817 2,817 Direct
2018-02-28 81,683 81,683 Direct
2019-02-10 100,000 100,000 Direct
2019-08-10 150,000 150,000 Direct
2021-02-10 20,250 20,250 Direct
2021-02-10 60,750 60,750 Direct
2021-02-10 39,465 39,465 Direct
2021-02-10 41,535 41,535 Direct
9,590 9,590 Direct
14,385 14,385 Direct
65,137 65,137 Direct
114,831 114,831 Direct
Footnotes
  1. This sale was made in connection with a Rule 10b5-1 Trading Plan for The Welch Family Trust u/a dtd 04/03/1996 ("The Welch Family Trust").
  2. This price represents the weighted average sale price of the shares sold by The Welch Family Trust in multiple transactions at prices ranging from $9.00 to $9.37 per share. Upon request by the staff of the Securities and Exchange Commission, Infinera Corporation (the "Company") or a security holder of the Company, Dr. Welch will provide full information regarding the number of shares sold at each separate price.
  3. These shares are held directly by The Welch Family Trust, for which Dr. Welch is a trustee.
  4. This price represents the weighted average sale price of the shares sold by The Welch Family Trust in multiple transactions at prices ranging from $9.18 to $9.40 per share. Upon request by the staff of the Securities and Exchange Commission, the Company or a security holder of the Company, Dr. Welch will provide full information regarding the number of shares sold at each separate price.
  5. These shares are held directly by LRFA, LLC, for which Dr. Welch is the sole managing member.
  6. These shares are held directly by The Welch Family Heritage Trust I u/I dated 9/24/01, for which Dr. Welch is a trustee.
  7. These shares are held directly by The Welch Group, L.P., for which Dr. Welch is a general partner.
  8. These shares are held directly by Dr. Welch as a trustee for his children. Dr. Welch disclaims beneficial ownership of the shares held in trust for his children, and this report shall not be deemed an admission that Dr. Welch is the beneficial owner of the shares held in trust for his children for purposes of Section 16 or for any other purpose.
  9. This option is fully-vested.
  10. Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Company.
  11. These RSUs vest in three annual installments beginning on May 5, 2016.
  12. These RSUs vest in full on May 5, 2018.
  13. These RSUs vest in four annual installments beginning on May 5, 2017.
  14. These RSUs vest in four annual installments beginning on May 5, 2018.